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1. Introduction
The EFSA Panel on Genetically Modiﬁed Organisms (GMO) has previously assessed the single events
Bt11, MIR162, MIR604 and GA21 as well as different stacked events corresponding to combinations of
these events (Table 1). In the framework of the risk assessment of the four-event stack
Bt11 9 MIR162 9 MIR604 9 GA21, the GMO Panel also assessed all the subcombinations of this stacked
event including those not previously assessed such as the two-stack maize event Bt11 9 MIR162
(application EFSA-GMO-DE-2009-66, EFSA GMO Panel, 2015). This subcombination, the two-stack maize
event Bt11 9 MIR162, was obtained by conventional crossing and data on the levels of the newly
expressed proteins were produced and provided by the applicant. The GMO Panel assessed this information
to determine whether it has an impact on the opinion previously issued by the European Food Safety
Authority (EFSA) on the four-event stack Bt11 9 MIR162 9 MIR604 9 GA21 and its subcombinations.
1.1. Background and Terms of Reference as provided by the requestor
The completion of the risk assessment of the four-event stack maize event Bt11 9 MIR162 9
MIR604 9 GA21 and subcombinations independently of their origin (application EFSA-GMO-DE-2009-
66 of Syngenta), was followed by the decision of the European Commission authorising the food and
feed containing, consisting and produced from GM maize Bt11 9 MIR162 9 MIR604 9 GA21 and
subcombinations under Regulation (EC) 1829/2003 (Commission implementing decision 2016/1685/EU).
As laid down in Article 5 of this decision, the authorisation holder is requested to provide information on
the expression levels of the newly expressed proteins for some of the subcombinations if these were to
be created by targeted breeding.
On 8 November 2016, Syngenta informed the European Commission that the subcombination
Bt11 9 MIR162 will be produced by targeted breeding for commercialisation. Furthermore, on the
basis of Article 5 of the Commission implementing decision 2016/1685/EU, Syngenta sent information
to the European Commission on this subcombination relating to application EFSA-GMO-DE-2009-66. On
14 December 2016, the European Commission requested EFSA to assess this information and indicate
whether it has an impact on the opinion for this application adopted by EFSA. Subsequently, the GMO
Panel has evaluated the data and methodology provided and considered this information in the context
of its previous conclusions on application EFSA-GMO-DE-2009-66 of Syngenta.
2. Data and methodologies
2.1. Data
The applicant provided data in line with the GMO Panel guidelines (EFSA, 2007a and EFSA GMO
Panel, 2011) on the expression levels of the newly expressed proteins in the two-event stack
Bt11 9 MIR162.
Table 1: GMO Panel scientiﬁc opinions on the single maize events Bt11, MIR162, MIR604 GA21 and
stacks containing these single events.
Event Application EFSA Scientiﬁc Opinions
Bt11 C/F/96/05.10
EFSA-GMO-RX-Bt11
EFSA-M-2012–0232(a)
EFSA (2005),
EFSA (2009a),
EFSA GMO Panel (2012b)
MIR162 EFSA-GMO-DE-2010-82 EFSA GMO Panel (2012a)
MIR604 EFSA-GMO-UK-2005-11 EFSA (2009b)
GA21 EFSA-GMO-UK-2005-19
EFSA-GMO-RX-GA21
EFSA (2007b)
Bt11 3 GA21 EFSA-GMO-UK-2007-49 EFSA GMO Panel (2009)
MIR604 3 GA21 EFSA-GMO-UK-2007-48 EFSA GMO Panel (2010a)
Bt11 3 MIR604 EFSA-GMO-UK-2007-50 EFSA GMO Panel (2010b)
Bt11 3 GA21 3 MIR604 EFSA-GMO-UK-2008-56 EFSA GMO Panel (2010c)
Bt11 3 MIR162 3 MIR604 3 GA21 EFSA-GMO-DE-2009-66 EFSA GMO Panel (2015)
Additional information on GM maize Bt11 3 MIR162 3 MIR604 3 GA21
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2017;15(3):4745
Two studies were provided which included data on the levels of the newly expressed proteins,
Cry1Ab, PAT, PMI and Vip3Aa20 in the two-event stack and the corresponding singles Bt11 and
MIR162 (Bednarcik, 2014, 2015).1 Bednarcik (2014) contains data derived from plants grown in one
location in one season and is therefore in line with the previous GMO Panel guidelines for the risk
assessment of genetically modiﬁed (GM) plants containing stacked transformation events (EFSA,
2007a). The other study, Bednarcik (2015) contains data derived from plants grown in three locations
in one season and is therefore in line with the latest GMO Panel guidelines for the risk assessment of
GM plants (EFSA GMO Panel, 2011) and also with the requirements as laid down in the Implementing
Regulation (EU) No 503/2013.2 Although both studies were considered by the GMO Panel, the risk
assessment was based on the Bednarcik (2015) study which follows the latest requirements (EFSA
GMO Panel, 2011 and Implementing Regulation (EU) No 503/2013).
2.2. Methodologies
In delivering this statement, the GMO Panel took into account the information provided by the
applicant and carried out its scientiﬁc risk assessment based on the appropriate principles described in
its guidelines for the risk assessment of GM plants (EFSA GMO Panel, 2011 and Implementing
Regulation (EU) No 503/2013).
2.2.1. New information for the subcombination maize Bt11 3 MIR162 submitted
as part of the current mandate
Plants were grown under ﬁeld conditions in Brazil in 2013–2014 (one location, ﬁve replicate plots,
Bednarcik (2014)) and in USA in 2014 (three locations, ﬁve replicate plots, Bednarcik (2015)). In both
studies, the levels of Cry1Ab, PAT, PMI and Vip3Aa20 proteins in the two-event stack maize and the
two single events were quantiﬁed by enzyme-linked immunosorbent assay (ELISA). Protein levels were
determined in leaves (V6 and R1 stages), roots (V6 and R1 stages), whole plants (V6 and R1 stages),
pollen (R1 stage) and in grain (R6 and senescence stages) (Annex A) (Bednarcik, 2015).
3. Assessment
The GMO Panel assessed the levels of the newly expressed proteins in the two-event stack and the
respective singles. The levels of the newly expressed proteins Cry1Ab, PAT, Vip3Aa20 and PMI are
similar between the two-event stack Bt11 9 MIR162 and the corresponding single events Bt11 and
MIR162. Based on these data, there is no indication of an interaction between the events that would
affect the levels of the newly expressed proteins in this two-event stack maize Bt11 9 MIR162. This is
consistent with the conclusions of the GMO Panel for application EFSA-GMO-DE-2009-66.
4. Conclusions
Based on the analysis of the data provided, there is no indication of an interaction between the
events combined in maize Bt11 9 MIR162 that would affect the levels of the newly expressed proteins.
Thus, the GMO Panel considers that the new information for maize Bt11 9 MIR162 does not alter the
conclusions of the scientiﬁc opinion on application EFSA-GMO-DE-2009-66 (EFSA GMO Panel, 2015).
Documentation provided to EFSA
Letter from the European Commission, received on 14 December 2016, concerning a request to
analyse additional information related to the application for authorisation of food and feed containing,
consisting and produced from genetically modiﬁed maize Bt11 9 MIR162 9 MIR604 9 GA21 and
genetically modiﬁed maizes combining two or three of the events.
1 Bednarcik, 2014 (Report No: TK0215384) and Bednarcik, 2015 (Report No: TK0224852).
2 Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically
modiﬁed food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and
amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006. OJ L157, 8.6.2013, p. 1–48.
Additional information on GM maize Bt11 3 MIR162 3 MIR604 3 GA21
www.efsa.europa.eu/efsajournal 5 EFSA Journal 2017;15(3):4745
References
EFSA (European Food Safety Authority), 2005. Opinion of the Panel on Genetically Modiﬁed Organisms (GMO Panel)
on a request from the Commission related to the notiﬁcation for the placing on the market of insect-tolerant
genetically modiﬁed maize Bt11, for cultivation, feed and industrial processing, under Part C of Directive 2001/
18/EC from Syngenta Seeds. EFSA Journal 2005;3(5):213, 33 pp. doi:10.2903/j.efsa.2005.213
EFSA (European Food Safety Authority), 2007a. Guidance document of the Panel on Genetically Modiﬁed Organisms
(GMO Panel) on genetically modiﬁed organisms for the risk assessment of genetically modiﬁed plants containing
stacked transformation events. EFSA Journal 2007;5(7):512, 5 pp. doi:10.2903/j.efsa.2007.512
EFSA (European Food Safety Authority), 2007b. Opinion of the Panel on Genetically Modiﬁed Organisms (GMO Panel)
on application (Reference EFSA-GMO-UK-2005-19 and EFSA-GMO-RX-GA21) for the placing on the market of
glyphosate-tolerant genetically modiﬁed maize GA21, for food and feed uses, import and processing and for renewal
of the authorisation of maize GA21 as existing product, both under Regulation (EC) No 1829/2003 from Syngenta
Seeds S.A.S. on behalf of Syngenta Crop Protection AG. EFSA Journal 2007;5(10):541, 25 pp. doi:10.2903/j.efsa.
2007.541
EFSA (European Food Safety Authority), 2009a. Opinion of the Panel on Genetically Modiﬁed Organisms (GMO
Panel) on application reference EFSA-GMO-RX-Bt11 for renewal of the authorisation of existing products
produced from insect-resistant genetically modiﬁed maize Bt11, under Regulation (EC) No 1829/2003 from
Syngenta. EFSA Journal 2009;7(2):977, 13 pp. doi:10.2903/j.efsa.2009.977
EFSA (European Food Safety Authority), 2009b. Scientiﬁc Opinion of the Panel on Genetically Modiﬁed Organisms
(GMO Panel) on application (Reference EFSA-GMO-UK-2005-11) for the placing on the market of insect-
resistant genetically modiﬁed maize MIR604 event, for food and feed uses, import and processing under
Regulation (EC) No 1829/2003 from Syngenta Seeds S.A.S on behalf of Syngenta Crop Protection AG. EFSA
Journal 2009;7(7):1193, 26 pp. doi:10.2903/j.efsa.2009.1193
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2009. Scientiﬁc Opinion on application
(Reference EFSA-GMO-UK-2007-49) for the placing on the market of insect resistant and herbicide tolerant
genetically modiﬁed maize Bt11 9 GA21, for food and feed uses, import and processing under Regulation (EC)
No 1829/2003 from Syngenta Seeds. EFSA Journal 2009;7(9):1319, 27 pp. doi:10.2903/j.efsa.2009.1319
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2010a. Scientiﬁc Opinion on application (EFSA-
GMO-UK-2007-48) for the placing on the market of insect resistant and herbicide tolerant genetically modiﬁed
maize MIR604 9 GA21 for food and feed uses, import and processing under Regulation (EC) No 1829/2003
from Syngenta Seeds. EFSA Journal 2010;8(5):1611, 30 pp. doi:10.2903/j.efsa.2010.1611
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2010b. Scientiﬁc Opinion on application
(Reference EFSA-GMO-UK-2007-50) for the placing on the market of insect resistant and herbicide tolerant
genetically modiﬁed maize Bt11 9 MIR604, for food and feed uses, import and processing under Regulation
(EC) No 1829/2003 from Syngenta Seeds. EFSA Journal 2010;8(5):1614, 30 pp. doi:10.2903/j.efsa.2010.1614
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2010c. Scientiﬁc Opinion on application (Reference
EFSA-GMO-UK-2008-56) for the placing on the market of insect resistant and herbicide tolerant genetically
modiﬁed maize Bt11 9 MIR604 9 GA21, for food and feed uses, import and processing under Regulation (EC) No
1829/2003 from Syngenta Seeds. EFSA Journal 2010;8(5):1616, 30 pp. doi:10.2903/j.efsa.2010.1616
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2011. Guidance for risk assessment of food and
feed from genetically modiﬁed plants. EFSA Journal 2011;9(5):2150, 37 pp. doi:10.2903/j.efsa.2011.2150
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2012a. Scientiﬁc Opinion on application (EFSA-
GMO-DE-2010-82) for the placing on the market of insect-resistant genetically modiﬁed maize MIR162 for food
and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta. EFSA Journal
2012;10(6):2756, 27 pp. doi:10.2903/j.efsa.2012.2756
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2012b. Scientiﬁc Opinion updating the risk
assessment conclusions and risk management recommendations on the genetically modiﬁed insect resistant
maize Bt11. EFSA Journal 2012;10(12):3018, 104 pp. doi:10.2903/j.efsa.2012.3018
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2015. Scientiﬁc Opinion on an application by
Syngenta (EFSA-GMO-DE-2009-66) for placing on the market of herbicide tolerant and insect resistant maize
Bt11 9 MIR162 9 MIR604 9 GA21 and subcombinations independently of their origin for food and feed uses,
import and processing under Regulation (EC) No 1829/2003. EFSA Journal 2015;13(12):4297, 34 pp. doi:
10.2903/j.efsa.2015.4297
Abbreviations
ELISA enzyme-linked immunosorbent assay
GM genetically modiﬁed
GMO EFSA Panel on Genetically Modiﬁed Organisms
LOD limit of detection
Additional information on GM maize Bt11 3 MIR162 3 MIR604 3 GA21
www.efsa.europa.eu/efsajournal 6 EFSA Journal 2017;15(3):4745
Annex A – Means, standard deviations and ranges (n = 15) of protein
levels in plant tissues from different developmental stages (lg/g dry
weight) from maizes Bt11 3 MIR162, Bt11 and MIR162
Tissue Stage Hybrid
Protein
Cry1Ab PAT Vip3Aa20 PMI
Leaves V6 Bt11 3 MIR162 195(a)  149(b) 0.784  0.677 187  102 13.4  7.95
(95.9–280)(c) (0.219–1.15) (138–282) (7.18–17.7)
Bt11 176  149 0.721  0.677 --- ---
(72.8–239) (0.167–1.16)
MIR162 --- --- 228  102 11.1  7.95
(142–339) (5.37–16.7)
R1 Bt11 3 MIR162 73.1  99.8 0.788  0.586 198  73.7 13.4  5.8
(13.2–171) (0.263–1.14) (137–243) (9.24–17)
Bt11 48.3  99.8 0.858  0.586 --- ---
(7.01–123) (0.372–1.18)
MIR162 --- --- 190  73.7 12.4  5.8
(87.5–303) (8.99–19.7)
Roots V6 Bt11 3 MIR162 65.5  16.1 0.915  0.344 91.2  61.7 8.45  5.23
(53.2–78.3) (0.563–1.26) (55.7–126) (6.26–14.5)
Bt11 62.4  16.1 0.929  0.344 --- ---
(48.3–72.2) (0.547–1.63)
MIR162 --- --- 94.4  61.7 8.17  5.23
(47.4–122) (5.14–13.5)
Roots R1 Bt11 3 MIR162 26.2  17.5 0.840  1.13 40.4  26.7 3.18  1.55
(14.3–39.2) (0.103–1.63) (11.6–64.3) (1.32–4.2)
Bt11 22.8  17.5 0.783  1.13 --- ---
(14.2–37.4) (0.0988–1.34)
MIR162 --- --- 40.2  26.7 3.32  1.55
(16.9–65.2) (1.87–4.89)
Whole
Plant
V6 Bt11 3 MIR162 150  109 0.944  0.516 250  150 11.1  5.7
(80.4–242) (0.463–1.21) (163–318) (6.28–15.1)
Bt11 129  109 0.900  0.516 --- ---
(69–201) (0.358–1.27)
MIR162 --- --- 229  150 9.44  5.7
(137–388) (5.03–13.3)
Whole
Plant
R1 Bt11 3 MIR162 36.0  46.3 0.978  0.197 119  57.9 7.07  2.64
(7.34–69.2) (0.716–1.21) (76.2–195) (4.79–9.57)
Bt11 28.5  46.3 0.939  0.197 --- ---
(6.1–60.8) (0.749–1.11)
MIR162 --- --- 152  57.9 7.62  2.64
(120–176) (5.41–9.15)
Kernels R6 Bt11 3 MIR162 5.02  2.08 – 99.9  18.1 2.4  0.94
(2.98–7.3) (< LOD(d)–0.0446) (65.8–138) (1.6–3.55)
Bt11 4.72  2.08 – --- ---
(3.19–6.72) (< LOD–0.0400)
MIR162 --- --- 115  18.1 2.66  0.94
(84.5–132) (1.91–3.73)
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Tissue Stage Hybrid
Protein
Cry1Ab PAT Vip3Aa20 PMI
Kernels Senescence Bt11 3 MIR162 5.21  2.7 – 76.5  40 1.75  0.49
(2.9–7.61) (< LOD–0.0574) (45.2–105) (1.33–2.12)
Bt11 4.79  2.7 – --- ---
(3.17–7.21) (< LOD–0.0505)
MIR162 --- --- 83.1  40 1.84  0.49
(50.3–106) (1.35–2.35)
Pollen R1 Bt11 3 MIR162 0.203  0.0802 – 54.5  27.5 3.47  1.98
(0.153–0.289) < LOD (40.2–82.2) (2.91–4.52)
Bt11 0.162  0.0802 – --- ---
(0.11 – 0.21) < LOD
MIR162 --- --- 48.6  27.5 3.77  1.98
(41.3–60.8) (2.67–9.23)
(a): Mean.
(b): Range.
(c): Standard deviation.
(d): LOD for PAT in kernel and pollen = 0.025 lg/g.
–: Not applicable.
---: Not assayed.
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